Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Frankfurt - Delayed Quote EUR

Invesque Inc. (7ZL.F)

0.0890
+0.0005
+(0.56%)
At close: April 30 at 8:30:31 AM GMT+2
Loading Chart for 7ZL.F
  • Previous Close 0.0885
  • Open 0.0890
  • Bid 0.0850 x --
  • Ask 0.1190 x --
  • Day's Range 0.0890 - 0.0890
  • 52 Week Range 0.0576 - 0.2120
  • Volume 11,160
  • Avg. Volume 186
  • Market Cap (intraday) 97.012M
  • Beta (5Y Monthly) 1.10
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5100
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Invesque Inc. operates as a health care real estate company in North America. The company's investment property portfolio includes investments in independent living, assisted living, memory care, skilled nursing, and medical office properties. It also includes investments in owner occupied seniors housing properties, including the ownership of real estate properties, as well as provides management services. The company is headquartered in Vancouver, Canada.

invesque.com

1,448

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7ZL.F

View More

Performance Overview: 7ZL.F

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

7ZL.F
21.25%
S&P/TSX Composite index (^GSPTSE)
0.90%

1-Year Return

7ZL.F
49.35%
S&P/TSX Composite index (^GSPTSE)
14.40%

3-Year Return

7ZL.F
49.35%
S&P/TSX Composite index (^GSPTSE)
19.65%

5-Year Return

7ZL.F
49.35%
S&P/TSX Composite index (^GSPTSE)
68.07%

Compare To: 7ZL.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7ZL.F

View More

Valuation Measures

Annual
As of 4/29/2025
  • Market Cap

    96.15M

  • Enterprise Value

    426.35M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.04

  • Price/Book (mrq)

    0.77

  • Enterprise Value/Revenue

    2.90

  • Enterprise Value/EBITDA

    20.04

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -21.65%

  • Return on Assets (ttm)

    2.23%

  • Return on Equity (ttm)

    -26.77%

  • Revenue (ttm)

    166.94M

  • Net Income Avi to Common (ttm)

    -35.73M

  • Diluted EPS (ttm)

    -0.5100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.52M

  • Total Debt/Equity (mrq)

    329.89%

  • Levered Free Cash Flow (ttm)

    -205.04M

Research Analysis: 7ZL.F

View More

Company Insights: 7ZL.F

Research Reports: 7ZL.F

View More
Waiting for permission
Allow microphone access to enable voice search

Try again.